Understanding of Genetics by Men At Risk for Prostate Cancer

Launched by MAYO CLINIC · Sep 10, 2020

Keywords

ClinConnect Summary

This clinical trial is looking at how well African American and rural White men understand genetic testing related to localized prostate cancer. Researchers want to see if these men can better understand their prognosis, or expected outcome, thanks to new genetic technology. This understanding can help them make more informed decisions about their treatment options.

To participate, men must be between 40 and 95 years old, speak English, and be willing to provide consent. They should also identify as African American or White and live in either a rural area (with a population of less than 50,000) or an urban area (with more than 50,000). While women cannot participate in the study, they will play an important role by helping to review educational materials designed to aid understanding of genetic terms. If you or someone you know fits these criteria, this study could provide valuable insights into prostate cancer treatment planning.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • African-American or White men
• • Living in a rural or urban areas
• • Age 40 to 95 years old
• • Able and willing to provide informed consent
• • English-speaking
• • Willing to participate in the study.
• • This study will use the United States Department of Agriculture Office of Rural Development's definition of rural, which is as a city or town that has a population less than 50,000 inhabitants to define rural.
• • This study will use the United States Census Bureau's definition of urban, which is a city or town that has a population greater than 50,000 inhabitants to define urban.
• Exclusion Criteria:
• • Women will be excluded from participating in this study. However, women will be recruited to serve on an advisory panel to review the video-based educational tool for the comprehension of genomic terminology for prognostic genetic testing in patients with localized prostate cancer.